P-glycoprotein-mediated transport of itraconazole across the blood- brain barrier

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1738-1744

  Miyama, Tetsuo ^a   Takanaga, Hitomi ^a   Matsuo, Hirotami ^a   Yamano, Katsuhiro ^b   Yamamoto, Koujirou ^b   Iga, Tatsuji ^b   Naito, Mikihiko ^c   Tsuruo, Takashi ^c   Ishizuka, Hitoshi ^d   Kawahara, Yukinori ^d   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; KETOCONAZOLE; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY PERMEABILITY; DRUG BRAIN LEVEL; DRUG ELIMINATION; DRUG PENETRATION; DRUG UPTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031863588     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1738     Document Type: Article

References (33)

1. Back, D. J., and J. F. Tjia. 1991. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br. J. Clin. Pharmacol. 32:624-626.
2. Bailey, E., D. Karkovsky, and M. Rybak. 1990. The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy 10:146-153.
3. Blasberg, R. G., J. D. Fenstermacher, and C. S. Patlak. 1983. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 3:8-32.
4. Bohme, A., A. Ganser, and D. Hoelzer. 1995. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Ann. Hematol. 71:311-312.
5. Chen, C. J., J. E. Chin, K. Ueda, D. P. Clark, I. Pastan, M. M. Gottesman, and I. B. Roninson. 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381-389.
6. Chikhale, E. G., P. S. Burton, and R. T. Borchardt. 1995. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J. Pharmacol. Exp. Ther. 273:298-303.
7. Crane, J. K., and H.-T. Shin. 1993. Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. Am. J. Med. 95:445-446.
8. Devault, A., and P. Gros. 1990. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10:1652-1663.
9. Endicott, J. A., and V. Ling. 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171.
10. Gros, P., R. Dhir, J. Croop, and F. Talbot. 1991. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88:7289-7293.
11. Gupta, S., J. Kim, and S. Gollaspudi. 1991. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. J. Clin. Invest. 87:1467-1469.
12. Hait, W. N., J. F. Gesmonde, J. R. Murren, J.-M. Yang, H.-X. Chen, and M. Reiss. 1993. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells. Biochem. Pharmacol. 45:401-406.
13. Hammarlund-Udenaes, M., L. K. Paalzow, and E. C. M. de Lange. 1997. Drug equilibration across the blood-brain barrier - pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14:128-134.
14. Heykants, J., M. Michiels, W. Meuldermans, J. Monbaliu, K. Lavrijsen, A. Peer, J. C. Levron, R. Woestenborghs, and G. Gauwenbergh. 1987 The pharmacokinetics of itraconazole in animals and man: an overview. p. 223-249. In R. A. Fromtling (ed.), Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers, S.A., Philadelphia, Pa.
15. Kurosawa, M., M. Okabe, N. Hara, K. Kawamura, S. Suzuki, K. Sakurada, and M. Asaka. 1996. Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells. Ann. Hematol. 72:17-21.
16. Kwan, J. T. C., P. J. D. Foxall, D. G. C. Davidson, M. R. Bending, and A. J. Eisinger. 1987. Interaction of cyclosporin and itraconazole. Lancet ii:282.
17. Lannoy, I. A. M., R. S. Mandin, and M. Silverman. 1994. Renal secretion of vinblastine, vincristine and colchicine in vivo. J. Pharmacol. Exp. Ther. 268: 388-395.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
19. McClean, K. L., and G. J. Sheehan. 1994. Interaction between itraconazole and digoxin. Clin. Infect. Dis. 18:259-260.
20. Nishihara, K., J. Hibino, H. Kotaki, Y. Sawada, and T. Iga. Effect of itraconazole on pharmacokinetic behavior of digoxin in guinea pigs. Submitted for publication.
21. Pastan, I., and M. Gottesman. 1987. Multiple-drug resistance in human cancer. N. Engl. J. Med. 316:1388-1393.
22. Sakata, A., I. Tamai, K. Kawazu, Y. Deguchi, T. Ohnishi, A. Saheki, and A. Tsuji. 1994. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem. Pharmacol. 48:1989-1992.
23. Schinkel, A. H., J. J. M. Smit, O. Tellingen, J. H. Beijnen, E. Wagenaar, L. Deemter, C. A. A. M. Mol, M. A. Valk, E. C. Robanus-Maandag, H. P. J. Riele, A. J. M. Berns, and P. Borst. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
24. Schinkel, A. H., C. A. A. M. Mol, E. Wagenaar, L. Deemter, J. J. M. Smit, and P. Borst. 1995. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer 31A:1295-1298.
25. Shirai, A., M. Naito, T. Tatsuta, J. Dong, K. Hanaoka, K. Mikami, T. Oh-hara, and T. Tsuruo. 1994. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim. Biophys. Acta 1222:400-404.
26. 1). J. Pharmacol. Exp. Ther. 263:840-845.
27. Tatsuta, T., M. Naito, K. Mikami, and T. Tsuruo. 1994. Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differ. 5:1145-1152.
28. Thiebaut, F., T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. 1987. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735-7738.
29. Tsuji, A., T. Terasaki, Y. Takabatake, Y. Tenda, I. Tamai, T. Yamashima, S. Moritani, T. Tsuruo, and J. Yamashita. 1992. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51:1427-1437.
30. Vozeh, S., T. Uematsu, G. F. Hauf, and F. Follath. 1985. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval. J. Pharmacokinet. Biopharm. 13:203-212.
31. Vreugdenhil, G., J. M. M. Raemaekers, B. J. van Dijke, and B. E. de Pauw. 1993. Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia. Ann. Hematol. 67:107-109.
32. Yamamoto, K., Y. Sawada, and T. Iga. 1996. Pharmacodynamics analysis of contractile potentiation by cholinesterase inhibition in rats. J. Pharmacokinet. Biopharm. 24:327-348.
33. Yamaoka, K., and T. Nakagawa. 1983. A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J. Pharmacobio-Dyn. 6:595-606.